The "Hallux Valgus - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
This report delivers an in-depth understanding of the disease, historical and forecasted Hallux Valgus (Bunion) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The Hallux Valgus (Bunion) epidemiology division provides insights about historical and current patient pool and forecasted trends for each seven major countries. The Hallux Valgus epidemiology data are studied through Hallux Valgus possible division to give a better understanding of the Disease scenario in the 7MM.
The disease epidemiology covered in the report provides historical as well as forecasted Hallux Valgus (Bunion) epidemiology [segmented as Total Prevalent Cases of Hallux Valgus (by Age), Total Diagnosed Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Treated cases of Hallux Valgus] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.
Hallux Valgus (Bunion) Detailed Epidemiology Segmentation
In the year 2017, the total prevalent cases of Hallux Valgus were 172,039,751 in the 7MM. In the 7MM, among all the age groups 11,973,464 cases were accounted for less than 18 years, whereas for the age group 18-65 years and more than 65 years accounted for 109,690,287 and 50,376,000 number of cases for the year 2017.
The United States, in 2017, accounted for 70,259,180 cases (the highest number among the 7MM countries).
Among the EU-5 countries, the highest number of cases of Hallux Valgus were in Germany, i.e., 18,748,873 cases in the year 2017, which is estimated to rise by the year 2030.
In the 7MM, in 2017 diagnosed Hallux Valgus prevalent cases accounted for 137,631,801 in 2017.
The risk of hallux valgus is 2 to 3-fold higher in females compared to males. In the 7MM, the total gender-specific prevalent cases of Hallux Valgus was 41,609,614 for males and 96,022,186 for females in the year 2017
Among the 7MM, Japan accounted for 28,351,056, prevalent cases in 2017.
In the 7MM, 91,249,883 mild Hallux Valgus cases were observed in 2017. For moderate and severe Hallux Valgus type, 37,435,850 and 8,946,067 number of cases were observed in 2017, respectively.
What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus?
What are the key findings pertaining to the Hallux Valgus epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017-2030)?
What would be the total number of patients of Hallux Valgus across the 7MM during the study period (2017-2030)?
Among the EU5 countries, which country will have the highest number of patients during the study period (2017-2030)?
At what CAGR the patient population is expected to grow in the 7MM during the study period (2017-2030)?
What are the various recent and upcoming events which are expected to improve the diagnosis of Hallux Valgus?
Reasons to Buy
Develop business strategies by understanding the trends shaping and driving the global Hallux Valgus market
Quantify patient populations in the global Hallux Valgus market to improve product design, pricing, and launch plans
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hallux Valgus therapeutics in each of the markets covered
Understand the magnitude of Hallux Valgus population by its severity
The Hallux Valgus epidemiology report and model were written and developed by Masters and PhD level epidemiologists
The Hallux Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Topics Covered:
1. Key Insights
2. Executive Summary of Hallux Valgus
3. Epidemiology Forecast Flow
4. Hallux Valgus: Disease Background and Overview
4.2. Types of Bunions
4.3. Classification of Bunions
4.5. Risk Factors
4.6. Signs and Symptoms
4.8.1. Imaging Tests
4.8.2. Laboratory Tests
4.9. Diagnostic Algorithm
4.10. Diagnostic Guidelines
4.10.1. British Orthopedic Guidelines
4.10.2. Map of medicine health guides (Sheffield)
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale
5.3. Epidemiology Scenario: 7MM
5.4. The United States Epidemiology
5.5. EU-5 Epidemiology
5.10. The United Kingdom
5.11. Japan Epidemiology
8. About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/a67n8z
View source version on businesswire.com: https://www.businesswire.com/news/home/20201201005881/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900